Picture of Biotricity logo

BTCY — Biotricity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biotricity Inc reports results for the quarter ended in December - Earnings Summary

* Biotricity Inc  BTCY.OQ  reported a quarterly adjusted
loss of 9
cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 9
cents per share.
    * Revenue rose 27.4% to $2.46 million from a year ago;
analysts
expected $2.40 million. 
    * Biotricity Inc's reported EPS for the quarter was a loss
of 9
cents​.
    * The mean earnings estimate of analysts had fallen by
about 24.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biotricity Inc shares had risen by 56.3% this quarter.
    * The company reported quarterly net income of $4.75
million.
    * Wall Street's median 12-month price target for Biotricity
Inc is
$2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
14 at 09:42 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.09          -0.09          Met
 Sep. 30 2022      -0.07          -0.09          Missed
 Jun. 30 2022      -0.11          -0.10          Beat
 Mar. 31 2022      -0.11          -0.11          Met

Recent news on Biotricity

See all news